Filed by Marrone Bio Innovations, Inc.

(Commission File No. 001-36030)

Pursuant to Rule 425 under the Securities Act of 1933, as amended

and deemed filed under Rule 14a-12 under the

Securities Exchange Act of 1934, as amended

Subject Company: Marrone Bio Innovations, Inc. (Commission File No.: 001-36030)

Date: March 17, 2022

[The following presentation was posted on Marrone Bio Innovations, Inc.’s website on March 17, 2022.]